ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,270, issued on Dec. 30, was assigned to Harmony Biosciences Management Inc. (Plymouth Meeting, Pa.).
"Treatment of behavioral impairment in developmental and epileptic encephalopathy" was invented by Terri Sebree (Gladwyne, Pa.), Donna Gutterman (Raleigh, N.C.) and John Messenheimer (Moncure, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates to methods of treating behavioral problems and seizures in a subject having developmental and epileptic encephalopathy (DEE) by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein behavioral problems are treated in the subject."
The patent...